https://ir.mineralystx.com/ https://ir.mineralystx.com/news-events https://ir.mineralystx.com/news-events/press-releases https://ir.mineralystx.com/news-events/ir-calendar https://ir.mineralystx.com/news-events/presentations https://ir.mineralystx.com/news-events/email-alerts https://ir.mineralystx.com/sec-filings/all-sec-filings https://ir.mineralystx.com/corporate-governance https://ir.mineralystx.comhttps://mineralystx.com/about/#team https://ir.mineralystx.com/corporate-governance/board-committees https://ir.mineralystx.com/corporate-governance/governance-documents https://ir.mineralystx.com/corporate-governance/board-diversity https://ir.mineralystx.com/news-events/press-releases/detail/96/mineralys-therapeutics-appoints-jeffrey-a-munsie-as-chief https://ir.mineralystx.com/news-events/press-releases/detail/95/mineralys-therapeutics-reports-inducement-awards-under https://ir.mineralystx.com/news-events/press-releases/detail/94/mineralys-therapeutics-reports-fourth-quarter-2025 https://ir.mineralystx.com/news-events/press-releases/detail/93/mineralys-therapeutics-announces-fda-acceptance-of-nda-for https://ir.mineralystx.com/news-events/press-releases/detail/92/mineralys-therapeutics-to-announce-fourth-quarter-and-full https://ir.mineralystx.com/news-events/press-releases/detail/91/mineralys-therapeutics-reports-inducement-awards-under https://ir.mineralystx.com/news-events/press-releases/detail/90/mineralys-therapeutics-reports-inducement-awards-under https://ir.mineralystx.com/news-events/press-releases/detail/89/mineralys-therapeutics-provides-corporate-update-and https://ir.mineralystx.com/news-events/press-releases/detail/88/mineralys-therapeutics-phase-3-launch-htn-trial-of https://ir.mineralystx.com/news-events/press-releases/detail/87/mineralys-therapeutics-reports-inducement-award-under https://ir.mineralystx.com/news-events/press-releases/detail/86/mineralys-therapeutics-reports-third-quarter-2025-financial https://ir.mineralystx.com/news-events/press-releases/detail/85/data-for-lorundrostat-in-chronic-kidney-disease-and https://ir.mineralystx.com/news-events/press-releases/detail/84/mineralys-therapeutics-to-participate-in-upcoming-investor https://ir.mineralystx.com/news-events/press-releases/detail/83/mineralys-therapeutics-to-announce-third-quarter-2025 https://ir.mineralystx.com/news-events/press-releases/detail/82/mineralys-therapeutics-announces-late-breaking-presentation https://ir.mineralystx.com/news-events/press-releases/detail/81/mineralys-therapeutics-completes-enrollment-in-phase-2 https://ir.mineralystx.com/news-events/press-releases/detail/80/mineralys-therapeutics-presents-subgroup-analyses-of-phase https://ir.mineralystx.com/news-events/press-releases/detail/79/mineralys-therapeutics-announces-closing-of-upsized-287-5 https://ir.mineralystx.com/news-events/press-releases/detail/78/mineralys-therapeutics-announces-pricing-of-upsized-250-0 https://ir.mineralystx.com/news-events/press-releases/detail/77/mineralys-therapeutics-announces-proposed-public-offering https://ir.mineralystx.com/news-events/press-releases/detail/76/mineralys-therapeutics-reports-second-quarter-2025 https://ir.mineralystx.com/news-events/press-releases/detail/75/mineralys-therapeutics-to-announce-second-quarter-2025 https://ir.mineralystx.com/news-events/press-releases/detail/74/mineralys-therapeutics-announces-journal-of-the-american https://ir.mineralystx.com/news-events/press-releases/detail/73/mineralys-therapeutics-announces-positive-topline-results https://ir.mineralystx.com/news-events/press-releases/detail/72/mineralys-therapeutics-announces-late-breaking-presentation https://ir.mineralystx.com/news-events/press-releases/detail/71/mineralys-therapeutics-announces-late-breaking-presentation https://ir.mineralystx.com/news-events/press-releases/detail/70/mineralys-therapeutics-reports-first-quarter-2025-financial https://ir.mineralystx.com/news-events/press-releases/detail/69/mineralys-therapeutics-to-participate-in-the-bank-of https://ir.mineralystx.com/news-events/press-releases/detail/68/mineralys-therapeutics-to-announce-first-quarter-2025 https://ir.mineralystx.com/news-events/press-releases/detail/67/mineralys-therapeutics-announces-publication-of-pivotal https://ir.mineralystx.com/news-events/press-releases/detail/66/mineralys-therapeutics-announces-late-breaking-data-from https://ir.mineralystx.com/news-events/press-releases/detail/65/mineralys-therapeutics-to-host-kol-call-to-discuss-clinical https://ir.mineralystx.com/news-events/press-releases/detail/64/mineralys-therapeutics-announces-closing-of-underwriters https://ir.mineralystx.com/news-events/press-releases/detail/63/mineralys-therapeutics-announces-data-from-the-phase-2 https://ir.mineralystx.com/news-events/press-releases/detail/62/mineralys-therapeutics-announces-pricing-of-175-0-million https://ir.mineralystx.com/news-events/press-releases/detail/61/mineralys-therapeutics-announces-proposed-public-offering https://ir.mineralystx.com/news-events/press-releases/detail/60/mineralys-therapeutics-announces-positive-topline-results https://ir.mineralystx.com/news-events/press-releases/detail/59/mineralys-therapeutics-to-announce-topline-data-from https://ir.mineralystx.com/news-events/press-releases/detail/58/mineralys-therapeutics-reports-fourth-quarter-and-full-year https://ir.mineralystx.com/news-events/press-releases/detail/57/mineralys-therapeutics-to-announce-fourth-quarter-and-full https://ir.mineralystx.com/news-events/press-releases/detail/56/mineralys-therapeutics-completes-enrollment-in-explore-ckd https://ir.mineralystx.com/news-events/press-releases/detail/55/mineralys-therapeutics-announces-phase-2-clinical-trial-of https://ir.mineralystx.com/news-events/press-releases/detail/54/mineralys-therapeutics-reports-third-quarter-2024-financial https://ir.mineralystx.com/news-events/press-releases/detail/53/mineralys-therapeutics-to-participate-in-upcoming-investor https://ir.mineralystx.com/news-events/press-releases/detail/52/mineralys-therapeutics-to-announce-third-quarter-2024 https://ir.mineralystx.com/news-events/press-releases/detail/51/mineralys-therapeutics-completes-enrollment-ahead-of https://ir.mineralystx.com/news-events/press-releases/detail/50/mineralys-to-host-virtual-kol-event-on-the-unmet-medical https://ir.mineralystx.com/news-events/press-releases/detail/49/mineralys-therapeutics-completes-target-enrollment-in https://ir.mineralystx.com/news-events/press-releases/detail/48/mineralys-therapeutics-to-participate-in-the-wells-fargo https://ir.mineralystx.com/news-events/press-releases/detail/47/mineralys-therapeutics-reports-second-quarter-2024 https://ir.mineralystx.com/news-events/press-releases/detail/46/mineralys-therapeutics-to-announce-second-quarter-2024 https://ir.mineralystx.com/news-events/press-releases/detail/45/mineralys-therapeutics-appoints-biopharmaceutical-executive https://ir.mineralystx.com/news-events/press-releases/detail/44/mineralys-therapeutics-to-participate-in-the-goldman-sachs https://ir.mineralystx.com/news-events/press-releases/detail/43/mineralys-therapeutics-reports-first-quarter-2024-financial https://ir.mineralystx.com/news-events/press-releases/detail/42/mineralys-therapeutics-to-participate-in-the-bank-of https://ir.mineralystx.com/news-events/press-releases/detail/41/mineralys-therapeutics-to-announce-first-quarter-2024 https://ir.mineralystx.com/news-events/press-releases/detail/40/mineralys-therapeutics-reports-fourth-quarter-and-full-year https://ir.mineralystx.com/news-events/press-releases/detail/39/mineralys-therapeutics-to-announce-fourth-quarter-and-full https://ir.mineralystx.com/news-events/press-releases/detail/38/mineralys-therapeutics-announces-120-million-private https://ir.mineralystx.com/news-events/press-releases/detail/37/mineralys-therapeutics-to-participate-in-the-guggenheim https://ir.mineralystx.com/news-events/press-releases/detail/36/mineralys-therapeutics-appoints-minji-kim-ph-d-as-chief https://ir.mineralystx.com/news-events/press-releases/detail/35/mineralys-therapeutics-announces-first-subject-dosed-in https://ir.mineralystx.com/news-events/press-releases/detail/34/mineralys-therapeutics-further-defines-endotype-specific https://ir.mineralystx.com/news-events/press-releases/detail/33/mineralys-therapeutics-to-participate-in-three-upcoming https://ir.mineralystx.com/news-events/press-releases/detail/32/mineralys-therapeutics-reports-third-quarter-2023-financial https://ir.mineralystx.com/news-events/press-releases/detail/31/mineralys-therapeutics-presents-new-post-hoc-analysis-from https://ir.mineralystx.com/news-events/press-releases/detail/30/mineralys-therapeutics-to-announce-third-quarter-2023 https://ir.mineralystx.com/news-events/press-releases/detail/29/mineralys-therapeutics-announces-upcoming-poster https://ir.mineralystx.com/news-events/press-releases/detail/28/mineralys-therapeutics-expands-its-board-of-directors-with https://ir.mineralystx.com/news-events/press-releases/detail/27/mineralys-therapeutics-to-participate-in-the-cantor https://ir.mineralystx.com/news-events/press-releases/detail/26/mineralys-therapeutics-announces-jama-publication-of-full https://ir.mineralystx.com/news-events/press-releases/detail/25/mineralys-therapeutics-presents-target-htn-phase-2-trial https://ir.mineralystx.com/news-events/press-releases/detail/24/mineralys-therapeutics-selected-for-oral-poster https://ir.mineralystx.com/news-events/press-releases/detail/23/mineralys-therapeutics-to-participate-in-the-wells-fargo https://ir.mineralystx.com/news-events/press-releases/detail/22/mineralys-therapeutics-reports-second-quarter-2023 https://ir.mineralystx.com/news-events/press-releases/detail/21/mineralys-therapeutics-to-announce-second-quarter-2023 https://ir.mineralystx.com/news-events/press-releases/detail/20/mineralys-therapeutics-announces-expansion-of-planned-phase https://ir.mineralystx.com/news-events/press-releases/detail/19/mineralys-therapeutics-to-participate-in-the-jefferies https://ir.mineralystx.com/news-events/press-releases/detail/18/mineralys-therapeutics-reports-first-quarter-2023-financial https://ir.mineralystx.com/news-events/press-releases/detail/17/mineralys-therapeutics-announces-first-patient-dosed-in-the https://ir.mineralystx.com/news-events/press-releases/detail/16/mineralys-therapeutics-to-announce-first-quarter-2023 https://ir.mineralystx.com/news-events/press-releases/detail/15/mineralys-therapeutics-to-participate-in-the-bank-of https://ir.mineralystx.com/news-events/press-releases/detail/14/mineralys-therapeutics-reports-fourth-quarter-and-full-year https://ir.mineralystx.com/news-events/press-releases/detail/13/mineralys-therapeutics-presents-positive-lorundrostat https://ir.mineralystx.com/news-events/press-releases/detail/12/mineralys-therapeutics-to-announce-fourth-quarter-2022 https://ir.mineralystx.com/news-events/press-releases/detail/11/mineralys-therapeutics-abstracts-selected-to-be-presented https://ir.mineralystx.com/news-events/press-releases/detail/10/mineralys-therapeutics-announces-closing-of-initial-public https://ir.mineralystx.com/news-events/press-releases/detail/9/mineralys-therapeutics-announces-pricing-of-upsized-initial https://ir.mineralystx.com/news-events/press-releases/detail/5/mineralys-therapeutics-announces-positive-topline-phase-2 https://ir.mineralystx.com/news-events/press-releases/detail/6/mineralys-therapeutics-closes-118-million-oversubscribed https://ir.mineralystx.com/news-events/press-releases/detail/7/mineralys-therapeutics-appoints-adam-levy-as-chief https://ir.mineralystx.com/news-events/press-releases/detail/8/mineralys-therapeutics-closes-40-million-series-a-funding https://ir.mineralystx.com/privacy-policy https://ir.mineralystx.com/disclaimer https://ir.mineralystx.com/sitemap